Related references
Note: Only part of the references are listed.FX5, a non-steroidal glucocorticoid receptor antagonist, ameliorates diabetic cognitive impairment in mice
Dan-yang Zhu et al.
ACTA PHARMACOLOGICA SINICA (2022)
Amyloid β/PKC-dependent alterations in NMDA receptor composition are detected in early stages of Alzheimer′s disease
Carolina Ortiz-Sanz et al.
CELL DEATH & DISEASE (2022)
Molecular mechanisms underlying the N-methyl-D-aspartate receptor antagonists: Highlighting their potential for transdiagnostic therapeutics
Christina Driver et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2022)
NMDA and AMPA receptors dysregulation in Alzheimer's disease
Parvin Babaei
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
PSD-95: An Effective Target for Stroke Therapy Using Neuroprotective Peptides
Lola Ugalde-Trivino et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Alteration in NMDA Receptor Mediated Glutamatergic Neurotransmission in the Hippocampus During Senescence
Ashok Kumar et al.
NEUROCHEMICAL RESEARCH (2019)
Expression Changes of NMDA and AMPA Receptor Subunits in the Hippocampus in rats with Diabetes Induced by Streptozotocin Coupled with Memory Impairment
Xiao-Peng Wang et al.
NEUROCHEMICAL RESEARCH (2019)
The Impact of Prophylactic Lacosamide on LPS-Induced Neuroinflammation in Aged Rats
Mehtap Savran et al.
INFLAMMATION (2019)
Hippocampal Sequences During Exploration: Mechanisms and Functions
Celine Drieu et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
A Review of Various Antioxidant Compounds and their Potential Utility as Complementary Therapy in Multiple Sclerosis
Elzbieta Dorota Miller et al.
NUTRIENTS (2019)
Blockade of voltage-gated potassium channels ameliorates diabetes-associated cognitive dysfunction in vivo and in vitro
Wenhui Yan et al.
EXPERIMENTAL NEUROLOGY (2019)
Spatial memory in Huntington's disease: A comparative review of human and animal data
Yifat Glikmann-Johnston et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
Erythropoietin Protects Against Cognitive Impairment and Hippocampal Neurodegeneration in Diabetic Mice
Manal A. M. Othman et al.
BEHAVIORAL SCIENCES (2019)
Recombinant Human Erythropoietin Protects Against Hippocampal Damage in Developing Rats with Seizures by Modulating Autophagy via the S6 Protein in a Time-Dependent Manner
Qinrui Li et al.
NEUROCHEMICAL RESEARCH (2018)
Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications
Geert Jan Biessels et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Extended Erythropoietin Treatment Prevents Chronic Executive Functional and Microstructural Deficits Following Early Severe Traumatic Brain Injury in Rats
Shenandoah Robinson et al.
FRONTIERS IN NEUROLOGY (2018)
Alternative Erythropoietin Receptors in the Nervous System
Daniela Ostrowski et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Protective Activity of Erythropoyetine in the Cognition of Patients with Parkinson's Disease
Ivonne Pedroso et al.
BEHAVIORAL SCIENCES (2018)
The diabetic brain and cognition
Peter Riederer et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
The effects of aging in the hippocampus and cognitive decline
Luis E. B. Bettio et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
Neuroprotective effects of erythropoietin on Alzheimer's dementia model in rats
Betul Cevik et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2017)
Erythropoietin (EPO) ameliorates obesity and glucose homeostasis by promoting thermogenesis and endocrine function of classical brown adipose tissue (BAT) in diet-induced obese mice
Kazuki Kodo et al.
PLOS ONE (2017)
Erythropoietin ameliorates diabetes-associated cognitive dysfunction in vitro and in vivo
Meng Wang et al.
SCIENTIFIC REPORTS (2017)
Erythropoietin and Nonhematopoietic Effects
Alireza Nekoui et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2017)
Diabetes and Cognitive Impairment
Lindsay A. Zilliox et al.
CURRENT DIABETES REPORTS (2016)
Metabolomics in diabetic complications
Laura A. Filla et al.
MOLECULAR BIOSYSTEMS (2016)
Risk of dementia in patients hospitalised with type 1 and type 2 diabetes in England, 1998-2011: a retrospective national record linkage cohort study
Kate Smolina et al.
DIABETOLOGIA (2015)
Recombinant Human Erythropoietin to Target Cognitive Dysfunction in Bipolar Disorder: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial
Kamilla W. Miskowiak et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
MECHANISMS OF DIABETIC COMPLICATIONS
Josephine M. Forbes et al.
PHYSIOLOGICAL REVIEWS (2013)
Influence of Erythropoietin on Cognitive Performance during Experimental Hypoglycemia in Patients with Type 1 Diabetes Mellitus: A Randomized Cross-Over Trial
Peter Lommer Kristensen et al.
PLOS ONE (2013)
Erythropoietin Protects Pancreatic beta-cell Line NIT-1 Cells Against Cytokine-Induced Apoptosis via Phosphatidylinositol 3-Kinase/Akt Signaling
Hongxia Shuai et al.
ENDOCRINE RESEARCH (2011)
Effect of recombinant human erythropoietin on insulin resistance in hemodialysis patients
Essam Khedr et al.
HEMODIALYSIS INTERNATIONAL (2009)
Morris water maze: procedures for assessing spatial and related forms of learning and memory
Charles V. Vorhees et al.
NATURE PROTOCOLS (2006)
Share Paper
